Melanoma 2011: 21st Annual Cutaneous Malignancy Update (Melanoma)
Venue: Hilton San Diego Bayfront
|Event Date/Time: Jan 15, 2011||End Date/Time: Jan 16, 2011|
After participating in this course, the attendee should be able to:
â€¢ Demonstrate how newly discovered, evidence-based scientific information applies to the current practice of clinical dermatology.
â€¢ Describe the epidemiology and risk factors associated with the increasing incidence of cutaneous melanoma.
â€¢ Identify possible genetic mutations and etiologic factors in the melanoma patient and diagnose patients based on dermatologic manifestations.
â€¢ Illustrate the new melanoma staging system and how it impacts disease management.
â€¢ Evaluate and diagnose a variety of malignancies related to melanoma skin cancer.
â€¢ Determine techniques to improve patient compliance.
â€¢ Incorporate new therapies and treatment modalities for advanced melanoma patients including surgical techniques.
â€¢ Navigate the medico-legal aspects of caring for the melanoma patient.
Dermatologists, Pathologists, Dermatopathologists, Primary Care Physicians, Oncologists
Physicians (MD, DO)
Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Scripps Health designates this live activity for a maximum of 11 AMA PRA Category 1 Credit(s)â„¢. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for registered attendees in exchange for completed activity evaluation. Certificates of attendance are available, upon request, at the end of the course.
American Academy of Dermatology (AAD)
Scripps Clinicâ€™s Melanoma 2011: 21st Annual Cutaneous Malignancy Update is recognized by the American Academy of Dermatology for 10 hours of AAD Category 1 CME Credit and may be used toward the American Academy of Dermatologyâ€™s Continuing Education Award. Program #393400